Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.41 USD | -0.26% | +0.88% | -.--% |
May. 16 | ArriVent BioPharma, Inc. Appoints John Hohneker as Board of Directors | CI |
May. 08 | ArriVent BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 650M |
---|---|---|---|---|---|
Net income 2024 * | -78M | Net income 2025 * | -92M | EV / Sales 2024 * | - |
Net cash position 2024 * | 201M | Net cash position 2025 * | 502M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-6.64
x | P/E ratio 2025 * |
-6.55
x | Employees | 40 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.32% |
1 day | -0.26% | ||
1 week | +0.88% | ||
1 month | +16.30% | ||
3 months | -7.31% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 19.41 | -0.26% | 81,837 |
24-05-30 | 19.46 | +3.62% | 49,639 |
24-05-29 | 18.78 | -1.00% | 21,130 |
24-05-28 | 18.97 | -1.40% | 45,529 |
24-05-24 | 19.24 | +1.91% | 81,061 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-.--% | 650M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- AVBP Stock